Search

everythinglearnresearchcommunity

for

Search:↓

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Hirsutism can occur in women with PCOS even if their androgen levels are normal, making diagnosis challenging.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Men with more CAG repeats in the androgen receptor gene and lower testosterone levels may experience more severe COVID-19.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Women with hair loss have more androgen receptors in certain hair follicles.

The method accurately measures seven androgens in plasma and shows different hormone levels in females with acne and obesity.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

Pattern baldness is likely caused by a dominant gene influenced by testosterone levels, making it more common in men.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

More body hair in young Australian women is linked to higher androstenedione levels.

Increasing sleep by 41 minutes daily for a month showed no significant changes in metabolism or hormone levels in healthy women.

Finasteride treatment for three years changes certain polyamine levels in the blood but not in urine.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Androgens and estrogens are crucial for male reproductive health, affecting hormone levels and tissue function.

In STSD patients, the body compensates for low androgen levels by increasing another enzyme's activity.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.